About Selah Genomics
Selah Genomics is a company based in Greenville (United States) founded in 2012 was acquired by EKF in April 2014.. Selah Genomics has raised $900 thousand across 2 funding rounds from investors including EKF and VentureSouth. Selah Genomics operates in a competitive market with competitors including Omniome, Novogene Corporation, Rejuvenate Bio, HitGen and Source BioScience, among others.
- Headquarter Greenville, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Selah Genomics Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Selah Genomics
Selah Genomics has successfully raised a total of $900K across 2 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $450 thousand completed in March 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Debt – Conventional — $450,000
-
First Round
First Round
(11 Jun 2013)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2016 | Amount | Debt – Conventional - Selah Genomics | Valuation |
investors |
|
| Jun, 2013 | Amount | Seed - Selah Genomics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Selah Genomics
Selah Genomics has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include EKF and VentureSouth. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage ventures in the Southeast are supported by VentureSouth.
|
Founded Year | Domain | Location | |
|
Point-of-care and laboratory blood analyzers are developed by EKF.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Selah Genomics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Selah Genomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Selah Genomics Comparisons
Competitors of Selah Genomics
Selah Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Omniome, Novogene Corporation, Rejuvenate Bio, HitGen and Source BioScience, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| domain | founded_year | HQ Location |
Genomic services and solutions with NGS expertise are provided.
|
|
| domain | founded_year | HQ Location |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| domain | founded_year | HQ Location |
DNA-encoded libraries are developed for drug discovery applications.
|
|
| domain | founded_year | HQ Location |
Multiple genomic services are provided for analysis and diagnostics.
|
|
| domain | founded_year | HQ Location |
NGS-based diagnostic solutions for neonatal screening are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Selah Genomics
When was Selah Genomics founded?
Selah Genomics was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Where is Selah Genomics located?
Selah Genomics is headquartered in Greenville, United States.
Is Selah Genomics a funded company?
Selah Genomics is a funded company, having raised a total of $900K across 2 funding rounds to date. The company's 1st funding round was a Seed of $900K, raised on Jun 11, 2013.
What does Selah Genomics do?
Selah Genomics was founded in 2012 in Greenville, United States, as a clinical diagnostic company focused on the genomics sector. Services are offered to healthcare providers and the pharmaceutical industry, including next-generation sequencing, companion diagnostics for drug development, RNA sequencing, targeted sequencing from fresh-frozen or FFPE tissue, exome sequencing, qPCR, and bioinformatics support. A biorepository with clinical and molecular annotations of solid tumors is maintained.
Who are the top competitors of Selah Genomics?
Selah Genomics's top competitors include Novogene Corporation, Singular Genomics and Source BioScience.
Who are Selah Genomics's investors?
Selah Genomics has 2 investors. Key investors include EKF, and VentureSouth.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.